NewTimeSpace News: Tianqi Lithium Corporation (09696.HK) announced that a partial fire broke out during maintenance at Talison's Phase 3 chemical-grade lithium concentrate plant in Australia. The fire was put out promptly. All on-site staff were evacuated safely with no injuries. Major equipment and production lines remain intact, while the plant's production ramp-up progress may be affected.
NewTimeSpace News: Kintor Pharmaceutical Limited (09939.HK) announced that the interim results of the long-term human safety trial for its core product KT-939 were positive. None of the 119 subjects experienced any adverse skin reactions after 28 consecutive weeks of use, demonstrating a sound safety profile. Meanwhile, the Company has launched the registration application for KT-939 as a new cosmetic raw material, with relevant technical documents submitted to the National Institutes for Food and Drug Control.
NewTimeSpace News: SF HOLDING(06936.HK) will spend CNY 99.99 million to repurchase 2.87 million shares on Jun 10, 2026.
NewTimeSpace News: GCL TECH(03800.HK) will spend HKD 81.3 million to repurchase 109.09 million shares on Jun 10, 2026.
NewTimeSpace News: MIDEA GROUP(00300.HK) will spend CNY 45.39 million to repurchase 545.5 thousand shares on Jun 10, 2026.
NewTimeSpace News: WUXI APPTEC(02359.HK) will spend HKD 242.53 million to repurchase 2.03 million shares on Jun 10, 2026.
NewTimeSpace News: June 10, 2026, DLC ASIA(08210.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at HKD 32.58 million, decreased by 30.42% YoY
NewTimeSpace News: MNSO(09896.HK) will spend HKD 49.98 million to repurchase 1.93 million shares on Jun 10, 2026.
NewTimeSpace News: TENCENT(00700.HK) will spend HKD 500.68 million to repurchase 1.08 million shares on Jun 10, 2026.
NewTimeSpace News: CSPC Pharmaceutical Group Limited (01093.HK) announced that the Phase III clinical trial (KN026-003) evaluating the combination of Anistolimab (KN026), co-developed by its subsidiary Jinmant Bio and Alphamab Oncology, and the Group's self-developed Docetaxel (Albumin-bound) for Injection (HB1801) as first-line treatment for HER2-positive advanced breast cancer has successfully met the primary endpoint of progression-free survival (PFS). The results show statistically significant and clinically meaningful benefits with a favorable safety profile.
NewTimeSpace News: China High Speed Transmission Equipment Group Co., Ltd. (00658.HK) announced that after the current Board and auditor conducted an initial review of the final report by FTI Consulting, they deemed the report failed to fully and accurately reflect the essence of relevant agreements. The Board has authorised the Independent Investigation Committee to oversee a further independent investigation and appointed Grant Thornton Certified Public Accountants (Special General Partnership) as an independent third-party forensic advisor.
NewTimeSpace News: Hansoh Pharmaceutical Group Company Limited (03692.HK) announced that the New Drug Application (NDA) for its innovative drug HS-10568 Injection (partner code: SHR6508) was accepted by the National Medical Products Administration (NMPA) on June 9, 2026. It is indicated for secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease undergoing hemodialysis. HS-10568 is an allosteric modulator of calcium-sensing receptor (CaSR).
NewTimeSpace News: Shanghai Bao Pharmaceuticals Co., Ltd. (02659.HK) announced that the Investigational New Drug (IND) application for its self-developed subcutaneous infusion ceftriaxone sodium BJ007 has been approved by the U.S. Food and Drug Administration (FDA), authorizing clinical trials. According to Frost & Sullivan, no subcutaneous ceftriaxone sodium has been approved globally, and BJ007 is the first and only candidate drug in its class to enter clinical development.
NewTimeSpace News: Dongjiang Environmental Company Limited (00895.HK) announced that its non-wholly-owned subsidiary Daxiang Logistics intends to join the public tender for the road transportation and direct delivery project of finished steel products of Zhongnan Co., Ltd. The service term is one year from July 1, 2026 to June 30, 2027, with a proposed bidding budget of RMB 20 million. If successful in the tender, Daxiang Logistics will sign a Road Transportation Contract with Ouye Logistics.
NewTimeSpace News: China CITIC Financial Asset Management Co., Ltd. (02799.HK) announced that it has received the official reply (Jin Fu [2026] No. 316) from the State Administration of Financial Regulation approving the qualification of Mr. Liu Zeyun to serve as the Company's Chief Compliance Officer. His term of office took effect on June 3, 2026.
NewTimeSpace News: China International Software issued a voluntary announcement on June 10 for the official launch of allmeta Ontology v1.0, an actionable ontology platform tailored for enterprise AI deployment.
